Carrick Therapeutics

Summary

Seedtable Score

69

Locations

• Dublin

Company Size

• 51 - 101

Last Stage Round

• Series C

Industry

• Deep Tech
• Health Tech

Insights

Carrick Therapeutics, based in Dublin, shows strong potential due to its focus on innovative therapies for difficult-to-treat diseases. As a clinical-stage biopharmaceutical company, Carrick targets consumers in need of breakthrough treatments. Significant investments from high-profile venture capital firms demonstrate confidence in the company's strategic direction. Although the market is competitive with existing treatments and ongoing clinical trials, Carrick's emphasis on novel therapeutic approaches could differentiate it. By addressing patient suffering and slow progress in current treatments, Carrick is well-positioned to impact the healthcare sector meaningfully.

• Series C (2022-01-01) $60.0M

---

• Series A (2016-03-01) $95.0M

---

Investors

• GV Series C

---

• ARCH Venture Partners Series C

---

• Evotec Series C

---

• Rosetta Capital Series C

---

• Cambridge Innovation Capital Series C

---

• Lightstone Series A

---

• GV Series A

---

• ARCH Venture Partners Series A

---

• Evotec Series A

---

• Woodford Investment Management Series A

---

• Cambridge Innovation Capital Series A

---

Full Company Profile

Access details of the company management, and other intelligence on this company by registering for Seedtable

---